The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background: Type 2 diabetes is a global health concern, with an increased prevalence and high cost of treatment. Objective: The aim of this systematic review and meta-analysis was to determine the effect of vitamin D supplementation and improved vitamin D status on glycemia and insulin resistance in type 2 diabetic patients. Data Source: We searched PUBMED/Medline, Cumulative Index to Nursing and Allied Health, and Cochrane Library (until January 2017). Study Selection: Prospective clinical trials were selected evaluating the impact of vitamin D supplementation on glycosylated hemoglobin (HbA1c), serum fasting plasma glucose (FPG), and homeostatic model assessment of insulin resistance (HOMA-IR) in diabetic patients. Data Extraction and Synthesis: We used a random-effects model to synthesize quantitative data, followed by a leave-one-out method for sensitivity analysis. The systematic review registration was CRD42017059555. From a total of 844 entries identified via literature search, 24 controlled trials (1528 individuals diagnosed with type 2 diabetes) were included. The meta-analysis indicated a significant reduction in HbA1c [mean difference: -0.30%; 95% confidence interval (CI): -0.45 to -0.15, P < 0.001], FPG [mean difference: -4.9 mg/dL (-0.27 mmol/L); 95% CI: -8.1 to -1.6 (-0.45 to -0.09 mmol/L), P = 0.003], and HOMA-IR (mean difference: -0.66; 95% CI: -1.06 to -0.26, P = 0.001) following vitamin D supplementation and significant increase in serum 25-hydroxyvitamin D levels [overall increase of 17 ± 2.4 ng/mL (42 ± 6 nmol/L)]. Conclusions: Vitamin D supplementation, a minimum dose of 100 µg/d (4000 IU/d), may significantly reduce serum FPG, HbA1c, and HOMA-IR index, and helps to control glycemic response and improve insulin sensitivity in type 2 diabetic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.006 · Cited by 1,981
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Nutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-2042 · Cited by 1,129
Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T., Cooper, J. D., Dastani, Z., Li, R., Houston, D. K., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001383 · Cited by 1,046
von Hurst, P. R., Stonehouse, W., & Coad, J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992017 · Cited by 624 · cited 4×
“(12) similarly showed significant improvement in insulin resistance among insulin-resistant women, despite there”
BackgroundInfluentialAn immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394 · cited 1×
“Moreover, vitamin D may improve glucose metabolism systemically through its anti-inflammatory and immunomodulatory effects (96).”
BackgroundThe Diabetes Prevention Program Research Group (2005) · Diabetes · doi:10.2337/diabetes.54.5.1566 · Cited by 333 · cited 1×
“(99) to evaluate the clinical significance of vitamin D impact on glycemic control.”
Background
Cited by
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00126 · Cited by 1,143
Analysis of Association between Vitamin D Deficiency and Insulin Resistance
Szymczak-Pajor, I., & Śliwińska, A. (2019) · Nutrients · doi:10.3390/nu11040794 · Cited by 335
Role of Vitamin D Beyond the Skeletal Function: A Review of the Molecular and Clinical Studies
Umar, M., Sastry, K. S., & Chouchane, A. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061618 · Cited by 283
Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y. (2018) · Nutrients · doi:10.3390/nu10030375 · Cited by 266
“Some observational studies indicated that supraphysiological dosing of vitamin D could be harmful; however, the most common dosing of supplementation, 2000 IU/day, was much lower than that, as well as than the debated dosing required for efficacy, 4000 to 5000 IU/day [13,40].”
BackgroundResultRusińska, A., Płudowski, P., Walczak, M., Borszewska-Kornacka, M. K., Bossowski, A., Chlebna-Sokół, D., Czech-Kowalska, J., Dobrzańska, A., Franek, E., Helwich, E., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00246 · Cited by 264
Raygan, F., Ostadmohammadi, V., Bahmani, F., & Asemi, Z. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.007 · Cited by 112
“Mirhosseini et al. (2017) found that vitamin D supplementation, a minimum dose of 4000 IU/day, significantly decreased FPG, HbA1c, and HOMA-IR, and improved insulin sensitivity in people with T2DM.”
Wang, Y., Yang, S., Zhou, Q., Zhang, H., & Yi, B. (2019) · Kidney and Blood Pressure Research · doi:10.1159/000498838 · Cited by 60
Cho, J., Scragg, R., Pandol, S. J., & Petrov, M. S. (2021) · Clinical and Translational Science · doi:10.1111/cts.12837 · Cited by 35
Metadata
- Authors
- Mirhosseini, N., Vatanparast, H., Mazidi, M., & Kimball, S. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2017-07-03
- Volume
- 102
- Issue
- 9
- Pages
- 3097-3110
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2727590134
- Cited by
- 155
- References
- 17
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.